Mannose binding lectin-dependent complement activation in emphysema
肺气肿中甘露糖结合凝集素依赖性补体激活
基本信息
- 批准号:10534745
- 负责人:
- 金额:$ 15.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-12-17 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsAntigen-Antibody ComplexApicalAreaBacterial InfectionsBindingBiological AssayBiological MarkersBiologyCalorimetryCause of DeathCell surfaceCellsChronic Obstructive Pulmonary DiseaseCo-ImmunoprecipitationsCodeCollaborationsCommittee MembersComplementComplement ActivationDataDepositionDevelopmentDiseaseDisease ProgressionEnergy TransferEnsureEnvironmentEnzymatic BiochemistryEnzyme-Linked Immunosorbent AssayEpithelial CellsEpitheliumEventFluorescenceFluorescence Resonance Energy TransferHealthHumanIn VitroIncidenceIndividualInfectionInflammationInjuryKidneyLectinLinkLiquid substanceLungLung diseasesMASP2 geneMannose Binding LectinMeasurementMeasuresMentorsMusMyocardial IschemiaPathogenicityPathway interactionsPeptide HydrolasesPhasePoint MutationPositioning AttributePredispositionProtease InhibitorProtein IsoformsPulmonary EmphysemaPulmonary InflammationReperfusion TherapyReportingResearchResearch PersonnelRoleSamplingSerineSerine ProteaseSerine Proteinase InhibitorsSerumSeverity of illnessSignal TransductionSmokeSmokerSmokingSterilityStructure of parenchyma of lungSurfaceTechniquesTestingTissuesTitrationsTrainingTranslatingTrypsinWild Type Mouseairway epitheliumalpha 1-Antitrypsinalpha 1-Antitrypsin Deficiencycell injurycigarette smokecigarette smoke-inducedcigarette smoke-induced inflammationcigarette smoke-induced lung injurycigarette smokingclinically relevantcomplement pathwaycomplement systemdesignearly onsetexperimental studyexposure to cigarette smokefluorescence lifetime imagingfollower of religion Jewishimprovedin vivoinhibitorlung injurymortalitymouse modelnovelnovel therapeuticspathogenprotective pathwayrecruitresponseskillstissue injurytranslational study
项目摘要
Project summary
The mechanisms by which cigarette smoke (CS) activates the complement cascade to cause lung sterile
inflammation and COPD progression are not completely understood. Considering the critical role of
complement in pathogen-induced inflammation, selective inhibition of the mannose-binding lectin (MBL)
complement pathway may result in decreased CS-induced inflammation and emphysema-like airspace
enlargement without an indiscriminate inhibition of complement's response to pathogens. In Aim 1 we propose
to investigate a novel mechanism of CS-induced lung injury; focusing on whether mannose-binding lectin
associated serine protease-2 (MASP-2), the central protease in the MBL pathway, is necessary to induce
inflammation and emphysema during CS exposure. In Aim 2 we will investigate whether alpha-1 antitrypsin, a
major serine protease inhibitor, binds and inhibits MASP-2. My proposal addresses the clinically relevant
question whether selective targeting of complement cascade via MASP-2 inhibition ameliorates lung
inflammation and emphysema development in relevant murine models of CS exposure. Our animal studies are
complemented by measurements of MASP-2 levels and activity in samples from active smokers with and
without COPD.
The design and implementation of the proposed coursework and experiments will assist me in gaining
expertise in complement biology, enzymology, and perfect my skills in lung stereology. I will train in new
techniques, such as miscroscale thermophoresis, isothermal titration calorimetry, and fluorescence resonance
energy transfer, FRET - fluorescence lifetime imaging microscopy, FLIM to study alpha-1 antitrypsin binding to
MASP-2. These skills and the new research focus on the role of complement system in CS-induced sterile
inflammation will allow me to become an independent investigator in a different area of research than my
mentor, Dr. Petrache. My committee members and collaborators are strategically positioned to assist
me in completing this proposal. National Jewish Health environment, the extraordinary expertise of the
mentoring team, and the track record of fruitful collaborations between Dr. Petrache and members of the
committee, will ensure a multifaceted and nurturing setting to facilitate my transition to independence.
Completion of this project will provide compelling experimental evidences that MASP-2 inhibition using
protease inhibitors ameliorates inflammation and lung injury in murine models of emphysema and it can be
harnessed as next generation therapeutics in human COPD disease.
项目总结
香烟烟雾激活补体级联导致肺不育的机制
炎症和COPD进展尚不完全清楚。考虑到网络的关键作用
病原体诱导的炎症中的补体,选择性抑制甘露糖结合凝集素(MBL)
补体途径可能导致CS诱导的炎症和肺气肿样空隙减少
放大,而不是不加区别地抑制补体对病原体的反应。在目标1中,我们建议
探讨CS致肺损伤的新机制;重点研究甘露糖结合凝集素
相关丝氨酸蛋白酶-2(MASP-2)是MBL途径中的中心蛋白酶,是诱导
接触CS时的炎症和肺气肿。在目标2中,我们将研究α-1抗胰蛋白酶、
主要的丝氨酸蛋白酶抑制剂,结合并抑制MASP-2。我的建议针对的是与临床相关的
质疑通过抑制MASP-2选择性靶向补体级联反应是否能改善肺部
CS暴露相关小鼠模型中炎症和肺气肿的发生。我们的动物研究是
补充测量MASP-2水平和活性的样本来自活跃吸烟者和
没有慢性阻塞性肺病。
拟议课程和实验的设计和实施将帮助我获得
补体生物学、酶学方面的专业知识,以及完善我的肺部体视学技能。我将在新的训练
差示温热电泳法、等温滴定量热法和荧光共振等技术
能量转移,FRET-荧光寿命成像显微镜,胶片研究α-1抗胰蛋白酶与
MASP-2。这些技巧和新的研究集中在补体系统在CS诱导的不孕中的作用
炎症将使我成为一名独立的研究员,从事不同于我的
导师,彼得拉什医生。我的委员会成员和合作者处于战略地位,可以协助
在完成这项建议方面,我谨此致谢。国家犹太人健康环境,超凡的专业知识
指导团队,以及Petrache博士与
委员会,将确保一个多方面和培育的环境,以促进我向独立的过渡。
该项目的完成将提供令人信服的实验证据,证明利用MASP-2抑制
蛋白水解酶抑制剂可减轻肺气肿小鼠模型的炎症和肺损伤
作为人类COPD疾病的下一代治疗药物。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
- DOI:10.1016/j.ebiom.2022.104262
- 发表时间:2022-10
- 期刊:
- 影响因子:11.1
- 作者:Serban, K. A.;Pratte, K. A.;Strange, C.;Sandhaus, R. A.;Turner, A. M.;Beiko, T.;Spittle, D. A.;Maier, L.;Hamzeh, N.;Silverman, E. K.;Hobbs, B. D.;Hersh, C. P.;DeMeo, D. L.;Cho, M. H.;Bowler, R. P.
- 通讯作者:Bowler, R. P.
Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions.
Alpha-1 抗胰蛋白酶抑制 fractalkine 介导的单核细胞-肺内皮细胞相互作用。
- DOI:10.1152/ajplung.00023.2023
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Mikosz,Andrew;Ni,Kevin;Gally,Fabienne;Pratte,KatherineA;Winfree,Seth;Lin,Qiong;Echelman,Isabelle;Wetmore,Brianna;Cao,Danting;Justice,MatthewJ;Sandhaus,RobertA;Maier,Lisa;Strange,Charlie;Bowler,RussellP;Petrache,Irina;Serb
- 通讯作者:Serb
Lectin Complement Pathway in Emphysema.
肺气肿中的凝集素补体途径。
- DOI:10.1164/rccm.201807-1380le
- 发表时间:2019
- 期刊:
- 影响因子:24.7
- 作者:Serban,KarinaA;Mikosz,Andrew;Strange,Charlie;Janciauskiene,SabinaM;Stolk,Jan;Jonigk,Danny;Sandhaus,RobertA;Petrache,Irina
- 通讯作者:Petrache,Irina
The multifaceted protease-anti-protease imbalance in COVID-19.
- DOI:10.1016/j.ebiom.2022.103973
- 发表时间:2022-04
- 期刊:
- 影响因子:11.1
- 作者:Goel K;Serban KA
- 通讯作者:Serban KA
A 56-Year-Old Man With Emphysema, Rash, and Arthralgia.
一名 56 岁男性,患有肺气肿、皮疹和关节痛。
- DOI:10.1016/j.chest.2021.06.045
- 发表时间:2021
- 期刊:
- 影响因子:9.6
- 作者:Goel,Khushboo;Maleki-Fischbach,Mehrnaz;George,MPatricia;Kim,Darlene;Richards,John;Wise,RobertA;Serban,KarinaA
- 通讯作者:Serban,KarinaA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karina Serban其他文献
Karina Serban的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karina Serban', 18)}}的其他基金
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10990669 - 财政年份:2024
- 资助金额:
$ 15.87万 - 项目类别:
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10737359 - 财政年份:2023
- 资助金额:
$ 15.87万 - 项目类别:
Mannose binding lectin-dependent complement activation in emphysema
肺气肿中甘露糖结合凝集素依赖性补体激活
- 批准号:
10310458 - 财政年份:2018
- 资助金额:
$ 15.87万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 15.87万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 15.87万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 15.87万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 15.87万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 15.87万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 15.87万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 15.87万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 15.87万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 15.87万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)